This review explores the effects of reproductive aging on sexual function, emphasizing how hormonal changes during menopause impact sexual desire, arousal, and satisfaction. Common symptoms include vaginal dryness, dyspareunia, and reduced libido, which can significantly affect quality of life. The decline in estrogen levels leads to physiological changes that contribute
This cohort study analyzed the relationship between different formulations of menopausal hormone therapy (HT) and breast cancer risk, finding that estrogen-only therapies (both bioidentical and animal-derived) did not significantly increase breast cancer risk, while synthetic progestins were more strongly associated with an increased risk. The study highlights a 12% increased
This review examines the role of testosterone therapy in treating hypoactive sexual desire disorder (HSDD) in postmenopausal women, highlighting its potential to improve sexual desire, satisfaction, and frequency of satisfying sexual encounters. While some studies support its efficacy, results are not uniform across trials. Testosterone influences sexual desire by acting
This 1995 article examines the evolving therapeutic role of estrogen replacement therapy (ERT) in preventing osteoporosis, heart disease, and cognitive decline in older adults. The study highlights estrogen’s potential benefits in preventing senile dementia and Alzheimer’s disease, as it may act as a growth factor for estrogen-responsive neurons, influence vascular
This observational study explored the effects of hormone replacement therapy (HRT) on inflammatory and hemostasis markers in elderly women aged 65 and older. It found that unopposed estrogen use was associated with a significant increase in C-reactive protein levels and Factor VIIc, while both unopposed estrogen and estrogen/progestin reduced plasminogen
This consensus statement provides guidelines for the use of testosterone therapy in women, focusing on the need for individualized treatment plans. It emphasizes that testosterone therapy can improve symptoms related to testosterone deficiency, such as low libido, poor mood, and reduced energy levels. However, risks such as acne, hirsutism, and
This observational study examined the link between hormone replacement therapy (HRT) use and the risk of breast cancer in postmenopausal women. It found that oral opposed estrogens (estrogen with progesterone) significantly increased the risk of breast cancer, with the risk rising with each additional prescription. In contrast, transdermal opposed estrogens,
This observational study examined the effects of different hormone replacement therapies (HRT) on C-reactive protein (CRP) levels, a marker of inflammation associated with cardiovascular disease. Women on oral HRT exhibited significantly higher CRP levels compared to those using intrauterine levonorgestrel combined with transdermal estradiol (LNG/TDE) or the control group, suggesting
This article reviews the evolving role of hormone replacement therapy (HRT) in postmenopausal women, examining its benefits and risks. It highlights that HRT, especially when started shortly after menopause, can reduce the risks of coronary heart disease (CHD), improve quality of life, alleviate menopausal symptoms, and reduce osteoporotic fractures. However,
This article reviews the hormonal and metabolic changes associated with aging, highlighting the impact of declining hormone levels on conditions such as frailty, diabetes, cardiovascular disease, and dementia. It discusses how hormone replacement therapy (HRT) has been used to counteract these effects but often leads to adverse side effects. The
